Alaleh Nouri - 16 Dec 2022 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, CLO, CORP. SEC.
Signature
/s/ Alaleh Nouri
Issuer symbol
PRCT
Transactions as of
16 Dec 2022
Net transactions value
-$1,703,942
Form type
4
Filing time
20 Dec 2022, 15:53:41 UTC
Previous filing
16 May 2022
Next filing
28 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Sale $839,348 -20,000 -42% $41.97 27,126 16 Dec 2022 Direct F1, F2, F3
transaction PRCT Common Stock Sale $369,668 -8,511 -31% $43.43 18,615 19 Dec 2022 Direct F1, F4
transaction PRCT Common Stock Sale $494,927 -11,489 -62% $43.08 7,126 19 Dec 2022 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 15, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.31 to $41.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 Includes 658 shares acquired on September 14, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.66 to $43.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.30 to $42.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.